Showing results (871-880 of 1,122) with videos related to
Sort By:
Pageof 113
Clinical & Experimental Ophthalmology|December 9, 2016
Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trialHortence Kamga, Jane McCusker, Mark Yaffe, et al.Pharmacotherapy|November 5, 2003
Putting an Ecstasy test kit to the test: harm reduction or harm induction?Rebecca A Murray, Paul L Doering, Lisa A Boothby, et al.American Journal of Surgery|August 21, 2018
Sarcopenia defined by a computed tomography estimate of the psoas muscle area does not predict frailty in geriatric trauma patientsAshley Mccusker, Muhammad Khan, Narong Kulvatunyou, et al.Cardiovascular and Interventional Radiology|June 19, 2014
Accessible or inaccessible? Diagnostic efficacy of CT-guided core biopsies of head and neck massesJane D Cunningham, Mark W McCusker, Sarah Power, et al.Nature Materials|July 16, 2008
Ordered silicon vacancies in the framework structure of the zeolite catalyst SSZ-74Christian Baerlocher, Dan Xie, Lynne B McCusker, et al.Brain, Behavior, and Immunity|February 19, 2017
Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenasesAlexandra K Brooks, Tiffany M Janda, Marcus A Lawson, et al.Elife|March 18, 2017
Scaffold-mediated gating of Cdc42 signalling fluxPéter Rapali, Romain Mitteau, Craig Braun, et al.Psychological Medicine|May 1, 1992
Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic typesA S Henderson, A F Jorm, A E Korten, et al.Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.Alzheimer Disease and Associated Disorders|March 1, 1997
Occupational risk factors for Alzheimer disease: a case-control studyR T Gun, A E Korten, A F Jorm, et al.Pageof 113